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Abstract
OBJECTIVES: To analyse the long-term outcomes of aortic valve (AV) repair
with biological patch in patient with non-rheumatic valve disease. METHODS:
From 1995 to 2011, 554 patients underwent elective (AV) repair; among them,
57 (mean age 45 ± 17 years) had cusp restoration using patch for non-rheumatic
valve disease. Seven (12%) patients had unicuspid valve, 30 (53%) patients
had bicuspid valve and 20 (35%) had tricuspid valve. Autologous pericardium
was used in 26 patients (7 treated, 19 non-treated), bovine pericardium in 26,
autologous tricuspid valve leaflet in 4 and aortic homograft cusp in 1. Patching
was used to repair perforation (n = 20, 35%), commissural defect (n = 18, 32%),
raphe repair (n = 17, 30%) or for cusp extension (n = 2, 3.5%). Echocardiographic
and clinical follow-up was 98% complete and mean follow-up was 72 ± 42.5
months. RESULTS: No hospital mortality. At 8 years, overall survival was 90 ±
5% and freedom from valve-related death was 96 ± 3%. Two patients...
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Abstract
OBJECTIVES: To analyse the long-term outcomes of aortic valve (AV) repair with biological patch in patient with non-rheumatic valve
disease.
METHODS: From 1995 to 2011, 554 patients underwent elective (AV) repair; among them, 57 (mean age 45 ± 17 years) had cusp restor-
ation using patch for non-rheumatic valve disease. Seven (12%) patients had unicuspid valve, 30 (53%) patients had bicuspid valve and 20
(35%) had tricuspid valve. Autologous pericardium was used in 26 patients (7 treated, 19 non-treated), bovine pericardium in 26, autolo-
gous tricuspid valve leaﬂet in 4 and aortic homograft cusp in 1. Patching was used to repair perforation (n = 20, 35%), commissural defect
(n = 18, 32%), raphe repair (n = 17, 30%) or for cusp extension (n = 2, 3.5%). Echocardiographic and clinical follow-up was 98% complete
and mean follow-up was 72 ± 42.5 months.
RESULTS: No hospital mortality. At 8 years, overall survival was 90 ± 5% and freedom from valve-related death was 96 ± 3%. Two patients
(3.5%) needed early reoperation for aortic regurgitation (AR); they underwent re-repair and the Ross procedure, respectively. Late reopera-
tion was necessary in 9 patients (16%) for AR (n = 4), stenosis (n = 3) or mixed disease (n = 2). They had the Ross procedure (n = 6) or pros-
thetic valve replacement (n = 3) with no mortality. At 8 years, freedom from reoperation was 75 ± 9%. Freedom from reoperation was
slightly higher in tricuspid compared with non-tricuspid valves (92 ± 7 vs 68 ± 11%, P = 0.18) and slightly higher for bovine (95 ± 5%) com-
pared with autologous pericardium (73 ± 11%, P = 0.38), but differences were statistically not signiﬁcant. In tricuspid valves, freedom from
reoperation was higher in perforation repair compared with other techniques (100 vs 50 ± 35%, P = 0.02). In bicuspid valves, freedom from
reoperation was similar between different repair techniques (P = 0.38). Late echocardiography showed AR 0-1 in 30 (53%) patients, AR 2 in
12 (21%) and no AR ≥ 3. Three patients presented a mean transvalvular gradient of 30–40 mmHg. Thromboembolic events occurred in 2
patients (0.6%/patient-year), bleeding events in 1 (0.3% /patient-year) and no endocarditis occurred.
CONCLUSIONS: AV repair with biological patch is feasible for various aetiologies. The techniques are safe and medium-term durability is
acceptable, even excellent for perforation repair in tricuspid valve morphology. Bovine pericardium is a good alternative to autologous
pericardium.
Keywords: Aortic regurgitation • Aortic valve repair • Patch repair • Unicuspid aortic valve • Bicuspid aortic valve
INTRODUCTION
The surgical approach towards the repair of the diseased aortic
valve had evolved signiﬁcantly in the last two decades. Surgical
strategies and techniques have been standardized to a certain extent.
Emerging results from specialised centers are providing better
understanding of the repair technique, and with that expanding its
indication, and its beneﬁcial diseased group. All of these changes
have reﬂected positively on the long-term outcomes.
Unlike the mitral valve, the aortic valve has limited cusp tissue.
Therefore, direct closure of the valve defect or after lesion resec-
tion is rarely an option in aortic valve repair, contrary to mitral
valve repair. Bahnson et al. in 1969 studied the use of pericardium,
peritoneum, pleura and fascia lata to reconstruct single aortic
cusps [1]. Further reports thereafter demonstrated variable experi-
mental usage of extravalvular biomaterial for aortic valve repair.
While early reports of patch repair were encouraging, there is
some concern regarding the durability of aortic valve repair in the
setting of patch repair of cusp defects.
In bicuspid aortic valve repair, the need for patch material has
been shown to reduce durability of the repair compared with
repair without patch [2, 3]. Similar results were found in tricuspid
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valve repair with patch material [4]. The reason for mitigated
results in valve repair with a patch may be multifactorial. First, the
need for patch material corresponds generally to a higher degree
of disease severity in terms of lesion size and aetiology of the
disease (e.g. rheumatic, congenital and endocarditis).
Secondly, the patch material itself may have limited functional
performance and may degenerate over time and this may be a
function of the type of material used for patching (autologous or
heterologous pericardium, artiﬁcial membrane).
During almost two decades, we have applied and developed
techniques of aortic valve repair including patch techniques in
various aetiologies of aortic valve disease with several types of
patches. In this study, we analysed medium to long-term out-
comes of patient having aortic valve repair with a patch. We also
sought to determine the factors; like disease aetiology, repair
technique, repair material and cause of failure that inﬂuence the
outcomes.
MATERIALS ANDMETHODS
Patient selection
This is a single-centre, observational study. From 1995 to 2011,
554 consecutive patients had elective aortic valve repair proce-
dures for various aetiologies of aortic valve disease. Patients
undergoing emergency operation for acute type A dissection
were excluded. For this study, we selected out from our institu-
tional database all patients having valve repair surgery with the
aid of biological tissue material to reconstruct aortic valve cusps.
Patients with rheumatic valve disease were excluded. We identi-
ﬁed 57 patients meeting the inclusion criteria with a mean age of
45 ± 17 years and 88% male. Aortic valve morphology was tricus-
pid in 20 (35%) patients, bicuspid in 30 (53%) and unicuspid in 7
(12%). Preoperative patient characteristics are listed in Table 1.
The study was approved by the ethics review board of the
hospital.
Surgical techniques
All procedures were performed using a median sternotomy, can-
nulation of the distal ascending aorta and venous cannulation of
the right atrium or both vena cavae in case of concomitant mitral
or tricuspid valve surgery. Myocardial arrest was achieved with
antegrade and ostial warm blood cardioplegia solution.
Aortotomy incision and valve exposure for inspection was per-
formed as previously described [3–8].
The surgical approach was performed according to our repair-
oriented functional classiﬁcation of aortic insufﬁciency [8]. All
included patients presented with AV lesions necessitating the use
of patch material to restore one or two cusps, or reconstruction of
Table 1: Clinical profile of all patients
Variables Tricuspid valve, n = 20 (35%) Bicuspid valve, n = 30 (53%) Unicuspid valve, n = 7 (12%)
Age years (mean ± SD, [range]) 59 ± 13.5 [39–82] 42 ± 10 [28–61] 16 ± 8 [6–28]
Male 15 (75%) 28 (93%) 7 (100%)
NYHA class
1 5 (25%) 11 (37%) 5 (71%)
2 4 (20%) 13 (43%) 0
3 9 (45%) 6 (20%) 2 (29%)
4 2 (10%) 0 0
Previous cardiac surgery 2 (10%) 1 (3%) 2 (29%)
Previous AV surgery 1 (5%) 0 1 (14%)
Previous balloon valvotomy 0 0 3 (43%)
Valve aetiology
Degenerative 3 (15%) 0 0
Connective tissue disease 1 (5%) 0 0
Endocarditis 15 (75%) 4 (13%) 0
Congenital 0 26 (87%) 7 (100%)
Fibroelastoma 1 (5%) 0 0
Grade of AR
1 2 (10%)a 3 (10%)b 3 (43%)c
2 2 (10%)a 4 (13%)b 0
3 9 (45%) 15 (50%) 3 (43%)
4 7 (35%) 8 (27%) 1 (14%)
Moderate-to-severe AV stenosis 0 2 (3%) 4 (57%)
Left ventricular ejection fraction
EF > 50 15 (75%) 27 (90%) 5 (71%)
EF 50–30 4 (20%) 2 (7%) 1 (14%)
EF < 30 1 (5%) 0 0
Left ventricular end-diastolic diameter (mm) 58 ± 9 59.5 ± 8 55 ± 12
aIndication for surgery was fibroelastoma (n = 1) or endocarditis (n = 3).
bIndication for surgery was aortic aneurysm with restrictive congenital raphe (n = 4) or endocarditis (n = 1).
cIndication for surgery was aortic valve stenosis.
SD: standard deviation; NYHA: New York Heart Association; AV: aortic valve; AR: aortic regurgitation, EF: ejection fraction.
Z. Mosala Nezhad et al. / European Journal of Cardio-Thoracic Surgery998
commissures. In patients with low grade AR, indication of patch
repair was cusp defect after resection of ﬁbroelastoma, calciﬁca-
tion or endocarditis lesion, or for mixed AV disease with restrictive
cusp motion (e.g. congenital raphe). Operative ﬁndings and repair
techniques are listed in Table 2. Patch repair was performed for
the following lesions: cusp defect like perforation or fenestration
and cusp restriction induced by raphe, ﬁbrosis or calciﬁcation.
Perforations were generally due to endocarditis, and rarely due
to resection of ﬁbroelastoma. Perforation was deﬁned as tissue
defect at the belly of the cusp with preservation of the free
margin. Fenestrations are congenital or degenerative defects
along the free margin of the cusp; they are generally located in
the commissural area. Regurgitation may be induced in the pres-
ence of a very large fenestration or by fenestration rupture.
Diffuse cusp restriction was considered a contraindication for
valve repair; however, localized restriction like a raphe in bicuspid
or unicuspid valve or localized degenerative lesion in tricuspid
valve was accepted for valve repair with patch material.
The surgical technique to repair cusp perforation was to have
the patch trimmed in a form resembling the present defect in
shape and adding 2 mm to its size, so as to prevent restriction of
cusp surface following patch implantation. The patch was applied
on the aortic surface of the cusp by running a continuous suture
using prolene 5/0 or 6/0 (Fig. 1A and B).
Fenestration repair followed the same principle with the primary
difference that one edge of the patch was used as neo-free margin
in case of ruptured fenestration or was used to reinforce the free
margin when the fenestration was not ruptured. In the latter case,
the running suture was passed over and over the free margin
(Fig. 1C and D). For ruptured fenestrations, patches were generally
used on one side of a commissure, while for large fenestrations
they were generally used on both sides of the commissure,
because large fenestrations are generally present on both sides.
In type 1 [9] bicuspid aortic valve with restricted raphe, patch
repair was used only if direct closure after raphe resection would
induce signiﬁcant restricted motion of the conjoint cusp. In our
early experience, a triangular patch was generally used to repair
the defect leaving the valve bicuspid (Fig. 2A and B). Later on, we
have adapted the technique of patching to respect the native
morphology of the valve. In symmetric or nearly symmetric bicus-
pid (180°/180°), the raphe repair consisted of a triangular patch
as described above leaving the valve bicuspid. However, in asym-
metric bicuspid ( conjoint cusp 240°/non-conjoint cusp 120°)
the raphe is generally not completely fused and after resection,
the valve is made tricuspid by using one patch to create a neo-
commissure at the place of the raphe (Fig. 2C and D). This tech-
nique, ﬁrst proposed by Tolan et al. [10], has been adapted by our
group and is described in detail in a previous work [11].
In unicuspid valves, the commissural reconstruction technique
was performed to make the valve bicuspid. The neocommissure is
placed opposite to the normal commissure, generally the non/left
commissure, at the place of one of the two raphes or in-between
Table 2: Operative data
Tricuspid valve (n = 20) Bicuspid valve (n = 30) Unicuspid (n = 7)
Cusp repair
Cusp prolapse repair
Central plication 5 (25%) 5 (17%) 0
Gore-Tex resuspension 0 13 (43%) 0
Raphe repair without patch
Direct closure after resection 0 3 (10%) 0
Cusp defect or restriction repair with patch
Perforation 15 (75%) 5 (17%) 0
Commissural reconstruction 5 (25%) 6 (20%) 7 (100%)
Raphe 0 17 (57%) 0
Fenestration 4 (20%) 1 (3%) 0
Cusp extension 0 2 (7%) 0
Patch materials used
Autologous treated pericardium 3 (15%) 2 (7%) 2 (29%)
Autologous non-treated pericardium 7 (35%) 11 (37%) 1 (14%)
Bovine pericardium 9 (45%) 13 (43%) 4 (57%)
Autologous tricuspid valve leaflet 1 (5%) 3 (10%) 0
Aortic valve homograft cusp 0 1 (4%) 0
Functional aortic annulus repair
Subcommissural annuloplasty 15 (75%) 15 (50%) 2 (27%)
Ascending aorta replacement 1 (5%) 5 (17%) 0
Reimplantation 1 (5%) 10 (33%) 1 (14%)
Partial root remodelling 0 4 (13%) 0
Aortic cross clamp time (mean ± SD, min) 86 ± 35 104 ± 29 92 ± 24
Cardiopulmonary bypass time (mean ± SD, min) 100 ± 40 119 ± 33 117 ± 34
Second pump runa 2 (10%) 3 (10%) 1 (14%)
Associated procedures
Coronary artery bypass grafting 3 (15%) 2 (7%) 0
Mitral or tricuspid valve repair 4 (20%) 1 (3%) 0
Myomectomy and resection of subaortic stenosis 1 (14%)
aFor residual moderate aortic insufficiency (AI) eccentric AI or too low coaptation, after repair all patients had AI 0-1.
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the two raphes as proposed by Aicher et al. [12] (Fig. 3). Raphes
were resected and cusps were thinned to optimize valve motion.
Unicuspid valve repair was the technique usually requiring
the largest patch in comparison with other types of valve repair
described above.
Cusp extension for non-rheumatic as well as rheumatic AV
disease was rarely performed in our experience. Generally, it
requires a patch strip 4–5 mm in height sutured along the free
margin from one commissure to the other to increase the func-
tional height and coaptation surface of the cusp [13, 14]. In this
series, it was performed in bicuspid valve on the conjoint cusp
after direct closure of raphe resection.
The decision for the type of patch material was principally at the
surgeon’s discretion. As no strong evidence exists on the superior-
ity of one material over another, different types of patches were
used during the study period and we currently use either bovine
pericardial patch or autologous pericardium. Treated autologous
pericardium, with a glutaraldehyde 0.6% solution, was used princi-
pally when patch repair was planned before starting valve assess-
ment and repair. When patch repair was indicated during valve
assessment, non-treated autologous or bovine pericardium was
used as both are readily available. Non-treated autologous was
favoured in cases of easy repair with less demanding technical
manoeuvres, like perforation patching, and bovine pericardium
was favoured in more complex repair like commissural reconstruc-
tion or when autologous pericardium was not available. Bovine
pericardial patch from Synovis® (Vascu-Guard, Surgical Innovation,
Deerﬁeld, IL, USA) was used until 2010, and then both bovine peri-
cardial patches from Synovis® and St Jude Medical (pericardial
patch with EnCap Technology, St Jude Medical, Inc., USA) were
used. The last one being thinner and available for immediate use
without rinsing, we found it more appropriate for AV repair.
In a few patients, autologous tricuspid valve leaﬂet was used as
patching material. Those cases were performed during the early
period of our experience (before 2004) in certain patients having
concomitant tricuspid valve repair. The reason to use this auto-
tissue was driven by the optimistic early results we had with the
autologous tricuspid valve patch in mitral valve repair. The use of
this material in aortic position was abandoned after cases of patch
dehiscence. In 1 patient, a patch made from cusp tissues of an AV
homograft was used. This opportunity occurred because AV re-
placement with a homograft was initially scheduled and at the
time the valve was judged amenable to repair with a patch, the
homograft was already prepared.
Echocardiographic assessment
Our echocardiographic protocol, derived from the American
Society of Echocardiography Guidelines [15], indicated that the
patients will have two-dimensional transthoracic echocardiog-
raphy, with Doppler methods to assess the direction and severity
of the valve regurgitation, upon elective admission, before dis-
charge and at regular intervals during follow-up. Similarly, all
patients had intraoperative transoesophageal echocardiography.
Only mild central residual AR was accepted post-repair; moderate
AR, eccentric AR or low coaptation (at annulus level) justiﬁed
second pump run for revision of the repair.
Figure 1: (A and B) Leaﬂet perforation in a case of aortic endocarditis repaired with a circular bovine pericardial patch. (C and D) Dual fenestration of the right-to-left
commissure repaired with bovine pericardial patch.
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Data collection and follow-up
Patient demographics and operative data were collected pro-
spectively in our institutional valve database and analysed retro-
spectively. Clinical follow-up was conducted through either
outpatient visits or telephone follow-up by a research nurse.
Information on survival status and valve-related complications, in-
cluding thromboembolism, haemorrhage, endocarditis, reopera-
tion and cardiovascular symptoms, was obtained. Data are
reported according to the guidelines for reporting mortality and
morbidity after valve surgery [16]. The closing interval for the
study was between May and September 2013. Clinical follow-up
Figure 2: (A and B) Tricuspidization of asymmetric type I bicuspid valve (120°/240°) using bovine pericardial patch to split the conjoint leaﬂet and raise the
commissure insertion point. (C and D) Raphe repair with triangular autologous patch in a nearly symmetric bicuspid valve.
Figure 3: (A) Exposition of a unicuspid valve, (B) resection of the raphes, (C) and (D) reconstruction of the neocommissure with patch.
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was 98% complete at a mean follow-up time of 6 ± 3.5 years.
Echocardiographic follow-up was 91% complete at a mean follow-
up time of 5 ± 4 years.
Statistical analysis
The statistical analysis was performed with SPSS v15.0 (IBM, Inc.,
Chicago, IL, USA). Categorical variables were reported as absolute
numbers and percentages. Continuous variables were expressed
as mean ± standard deviation. Linearized event rates were calcu-
lated for valve-related events. Survival and freedom from valve
reoperation were calculated using the Kaplan–Meier method and
compared using the log-rank test. Freedom from reoperation was
evaluated for different subgroups of valve morphology, patch ma-
terial and repair techniques. Repair techniques were compared
following the type and location of the repair; therefore, commis-
sural and fenestration repair were grouped and compared with
perforation repair and raphe repair with triangular patch. Very
small subgroups, such as the homograft patch (n = 1) and cusp ex-
tension (n = 2) were not taken into account in comparison ana-
lyses. Graphs were constructed using GraphPad Prism 5.0 (San
Diego, CA, USA). Statistical signiﬁcance was considered for a
P-value of ≤0.05.
RESULTS
Mortality and morbidity
There was no hospital mortality. Postoperatively, re-exploration
for bleeding occurred in 6 (10.5%) patients and superﬁcial sternal
wound infection in 2 (3.5%) patients. There were no thrombo-
embolic or bleeding events and no permanent pacemaker
implantations. During follow-up, 5 patients died. Causes of death
were unknown in 2 patients, sudden death in 1, sepsis in 1 and cir-
rhosis in 1. At 8 years, overall survival was 90 ± 5% and freedom
from valve-related death was 96 ± 3%. There was no late mortality
in the unicuspid valve group; overall survival was slightly higher in
the bicuspid compared with the tricuspid valve group (96 ± 4 vs
77 ± 23%, P = 0.24) (Fig. 4).
Valve reoperation
Two of 11 patients (3.5%), both with bicuspid valve, had early re-
operation for recurrent AR; one presented dehiscence of the
autologous tricuspid valve patch and the other presented residual
cusp prolapse and annular dilatation. They underwent re-repair
and the Ross procedure, respectively.
During the follow-up, 9 patients needed late AV reoperation
(bicuspid n = 7, tricuspid n = 1, unicuspid n = 1); one of them
had early re-repair. Late reoperation occurred after the mean
follow-up of 6 ± 4 years (range: 2–14). Indications for reoperation
were AR (bicuspid n = 3, tricuspid n = 1), stenosis (bicuspid n = 3)
and mixed disease (bicuspid n = 1, unicuspid n = 1). In patients
with AR, mechanisms of failure were cusp prolapse with annular
dilatation (n = 2) and unknown (n = 2). In patients with stenosis,
mechanisms were calciﬁcation (n = 2) and calciﬁcation with cusp
perforation (n = 1). In patients with mixed disease, mechanisms
were patch dehiscence with cusp calciﬁcation (n = 2). Those
patients underwent the Ross procedure (n = 6) or prosthetic
valve replacement (n = 3) with no mortality at reoperation.
At 8 years, freedom from aortic valve reoperation was 75 ± 9%.
Freedom from reoperation was slightly higher in tricuspid com-
pared with bicuspid/unicuspid together but the difference did
not reach statistical signiﬁcance (92 ± 7 vs 68 ± 11%, P = 0.18)
(Fig. 5A). Freedom from reoperation was slightly higher for
bovine pericardium (95 ± 5%) compared with autologous peri-
cardium (73 ± 11%) but the difference did not reach statistical
signiﬁcance (P = 0.38) (Fig. 5B). No difference were found be-
tween treated and non-treated autologous pericardium (80 ± 11
vs 86 ± 13%, P = 0.78). Among the 4 patients receiving autologous
tricuspid valve leaﬂet, 3 underwent late reoperation (freedom
from reoperation at 8 years: 50 ± 25%). In tricuspid valves,
freedom from reoperation was signiﬁcantly higher in perforation
repair compared with commissure/fenestration repairs (100 vs
50 ± 35%, P = 0.02) (Fig. 6A). In bicuspid valves, freedom from
reoperation was similar between the different techniques of
repair (commissure/fenestration repair 100% versus perforation
repair 60 ± 22% versus raphe repair with triangular patch
71 ± 15%, P = 0.38) (Fig. 6B).
Figure 4: (A) Actuarial survival curve showing overall survival in tricuspid, bicus-
pid and unicuspid valves. (B) Actuarial survival curve showing freedom from
valve-related death in tricuspid, bicuspid and unicuspid valves.
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Echocardiographic results
At follow-up, last echocardiography in non-reoperated patients
showed AR 0–1 in 30 (53%) patients, AR 2 in 12 (21%) and no
AR ≥ 3. Three patients presented mean transvalvular gradients of
36, 38 and 39 mmHg at 48, 112 and 161 months of follow-up, re-
spectively; 2 of them had bicuspid and 1 had unicuspid valve.
Valve-related events
Thromboembolic events occurred in 2 patients for a total of 335.5
patient-years of follow-up, corresponding to a linearized rate of
0.6%/patient-year. Bleeding event occurred in 1 patient corre-
sponding to a linearized rate of 0.3%/patient-year. No endocardi-
tis occurred.
DISCUSSION
In this study, we mainly looked at patients with class 1d (per-
foration) AR following our functional classiﬁcation and class 3
(cusp restricted motion) wherein regurgitation can be combined
with stenosis [8]. Those patients represent 10% of our global ex-
perience in AV repair from 1995 to 2011. Abnormal congenital
valve (unicuspid or bicuspid) was involved in 60% mainly with
type 3 lesion and tricuspid valve was involved in 40% mainly with
type 1d lesion. Surgically, tricuspid aortic valve requires relatively
simple repair with less added tissue compared with congenitally
abnormal valves that demand a more complex repair technique
with a larger amount of biomaterial and more combined repair
techniques on the cusp and the aortic root.
The results from this retrospective study show that AV repair
with patch, though complex, can be performed with low mortality
and an acceptable reoperation rate, even very low in certain indi-
cations like perforation repair in tricuspid aortic valve (TAV). Good
results have also been noted in unicuspid valves, but this subgroup
had a relatively shorter follow-up. Autologous tricuspid valve
leaﬂet patch is not recommended since it is fragile, which leads to
dehiscence, and bovine pericardium is at least as good as autolo-
gous pericardium.
Our analysis revealed excellent survival and this is largely
related to two factors. The ﬁrst and most important factor is
patient age. They were young with less comorbidities and better
recovery. The second factor is related to surgery: increasing the
number of routine elective surgeries has positively increased and
advanced technical conﬁdence and safety. Along with it is the op-
timization of perioperative care which together has affected valve-
related events.
Figure 6: (A) Actuarial survival curve showing freedom from aortic valve re-
operation in tricuspid valve regarding the type of repair technique performed:
perforation repair versus commissural and fenestration repair together. (B)
Actuarial survival curve showing freedom from aortic valve reoperation in bicus-
pid valve regarding the type of repair technique performed: perforation repair
versus commissure/fenestration repair versus raphe repair with triangular patch.
Figure 5: (A) Actuarial survival curve showing freedom from aortic valve re-
operation in tricuspid valve versus bicuspid and unicuspid valves together. (B)
Actuarial survival curve showing freedom from aortic valve reoperation in
bovine pericardial patch versus autologous pericardial patch.
A
D
U
LT
C
A
R
D
IA
C
Z. Mosala Nezhad et al. / European Journal of Cardio-Thoracic Surgery 1003
In our experience, early reoperation was almost always due to
technical reasons. In the beginning (1998 and 2003) we had two
incidents of reoperation due to unsuitable patch material and not
addressing correctly cusp and annulus lesions. On the other hand,
the mode of long-term failure was mixed, partially resulting from
technical failure and partially related to the ongoing degenerative
changes in bicuspid and unicuspid valve patients.
In perforation repair, patch reconstruction is anatomical not
functional. The free margin remains intact and cusp motion is not
affected. Our results are probably excellent in this regard particu-
larly in TAV. Schäfers et al. [17] also reported the mid-term
outcome of perforation or fenestration repair with patch to be sat-
isfactory. A similar principle applies to resection of valvular
abscess or vegetation/masses. We had 19 patients with endocardi-
tis. They had no recurrence of infection. Two of them had bicuspid
aortic valve and had late reoperation for mixed valve disease. This
makes the repair technique with patch very suitable in the pres-
ence of infected tissues or vegetations that require limited resec-
tion. Mayer et al. [18] reported satisfactory outcomes of valve
repair in infective endocarditis as opposed to valve replacement.
Similarly, d’Udekem et al. [19] reported valvular reconstruction
with patch after radical resection of infected tissues to provide an
excellent chance of eradication of the infection.
Other factors that would inﬂuence the outcome are patch
related. The size and the type of the material being used, and the
location and the extent of the patching are equally important. In
some cases, additional Gore-Tex sutures were added to the cusp
as an additional repair technique, which might as well have had
an inﬂuence on the longevity of the repair. Several authors have
well described various techniques as well as biomaterials to
restore the aortic valve with excellent early result and good
mid-term outcomes, in both paediatric and adult populations for
various pathologies [13, 20–23]. They have identiﬁed the use of
pericardium to be quite durable.
The added biomaterial naturally does not possess those native
characteristics of the cusp tissues and this could be one of the
reasons of patch failure. As the degeneration of the valve pro-
gresses with time, so does that of the patch. At reoperation, the
patch can be found matching the process of native cusp changes.
So patch failure is caused by patch dysfunction or/and signiﬁcant
native valve deterioration.
In our experience, we have found that patch use can be avoided
in BAV repair with the use of the reimplantation technique.
Effectively, this technique has shown to induce more intense and
more stable annuloplasty compared with the subcommissural annu-
loplasty. In BAV presenting generally large annulus, the consequence
of a more intense annuloplasty during surgery is the increase in
the ratio cusp/annulus surface resulting in a reduction of the need
for a patch to close the defect after raphe resection. Moreover,
we have shown that the reimplantation technique, despite the
relatively higher degree of restrictive annuloplasty, does not induce
increased postoperative transvalvular gradient and confer a
better durability compared with subcommissural annuloplasty [24].
We learnt from our experience that any available tissue material
can be used as a patch. In the last decades, as the experience of
many centres have accumulated, the literature has been enriched
with data reporting the use of the pericardium, autologous and
bovine, and the discussion about those is still ongoing and is con-
troversial. Duran et al. [25] reported favourable results of treated
autologous pericardium in comparison with bovine; however,
they have mainly used bovine pericardium in rheumatic disease
while autologous pericardium was used for various pathologies.
This would explain our similar results between bovine and autolo-
gous pericardium. Rheumatic valve disease is aggressive and
ongoing and it might have an impact on a xenograft in aortic pos-
ition. We would have a positive view of treated xenograft due to
commercial competitive efforts to improve decellularization and
ﬁxation processes. While brief treatment of autologous pericar-
dium with glutaraldehyde might not be sufﬁcient to stand the test
of time. As more variable pericardial xenografts (bovine, porcine
and equine), or other tissues, are being readily available for use,
the debate would increase unless strong preclinical or prospective
studies are presented.
This study reports medium-term outcomes of aortic valve
repair with a patch in non-rheumatic valve disease utilizing either
bovine or autologous pericardium with similar results. By report-
ing these results, we might have better insights into and guidance
towards better patient selection using certain techniques that
would beneﬁt the most from the repair procedure. Moreover, to
limit or restrict the use of patch material to speciﬁc conditions
that would be of more advantage, and when is possible with
better alternative, to avoid patching. The solution would be to
have close-to-ideal patch material that possesses cusp structure
and function and is surgically pliable and readily available for use.
STUDY LIMITATIONS
The main limitation of this study is related to its retrospective
design with the inherent risk of data misinterpretation and data
loss. Particulary, we found limitation deducting data related to
mechanisms of failure, or the speciﬁc outcome of the patch itself.
Our data gathering was from echocardiography and operative
notes. Unfortunately, outcomes of the patch itself were not system-
atically described. Furthermore, we evaluated our evolving experi-
ence in aortic valve repair with patch, and we have ﬁne-tuned our
approach. Early failure of these repaired valves could be related to
initial high tolerance of residual AR, technical evolution and under-
standing to address the entire components of the aortic valve. Our
cohort is small in number, in total and for each subgroup. This
limits the power of our analysis. Therefore, interpretation of the
results should be taken with caution and the patients need con-
tinuous follow-up to conﬁrm observations made at this stage.
CONCLUSIONS
Aortic valve repair with a biological patch is feasible for various
aetiologies. The techniques are safe and medium-term durability
is acceptable, even excellent for perforation repair in tricuspid
valve morphology. Repair durability in congenitally abnormal
valve is dependent on the degeneration process of the native as
well as the patch tissues. Bovine pericardium is a good alternative
to autologous pericardium.
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APPENDIX. CONFERENCE DISSCUSSION
Dr S. Thelin (Uppsala, Sweden): I found this manuscript really interesting and it
could be discussed for a long time, but in the interests of time I will give you
three short questions. First, I see that you included about 10 patients with grade
1 and 2 aortic regurgitation. I suppose that these patients also had other indica-
tions for surgery.
Dr Mosala Nezhad: That is true.
Dr Thelin: My question is, what degree of aortic regurgitation do you accept
postoperatively?
Dr Mosala Nezhad: Right now I can say that we should not accept any
degree of aortic regurgitation; however, trivial regurgitation is thought to be ac-
ceptable.
Dr Thelin: Trivial, so that is grade 1?
Dr Mosala Nezhad: Yes, 0 to 1.
Dr Thelin: Secondly, the diseases you treated have a higher incidence
among males. Still, there is an non-proportionate over-representation of
male patients in your material, up to 90 or 100% in some groups. Does
this reﬂect in some way the fact that women are more reluctant to choose
traditional surgery instead of valvuloplasty or do you have other explana-
tions for this?
Dr Mosala Nezhad: I can say from my very limited experience that this
centre is a centre that is dedicated fully to a valve repair procedure for indicated
patients. So deﬁnitely every patient will go through the process of consultation
and a discussion about the options that they would have. I believe that what-
ever has been presented before you and the audience here is what we had.
And Drs De Kerchove and Bhoodwani can support me here; they are senior to
me, and they have more experience with this, and I believe that male prefer-
ence for AV repair is not the case.
Dr Thelin: Finally, your results are impressive but in some subgroups the
results could have been even better if you had used traditional methods with
prosthetic implants. Have you in any way changed your indications during the
last year?
Dr Mosala Nezhad: I’m sorry, I couldn’t hear your question well.
Dr Thelin: For example, looking at tricuspid valves, some of your procedures
have quite a high degree of reoperations. Does this mean that you have
changed your indication and you go for more standard procedures in these
cases?
Dr Mosala Nezhad: Well, this study is mainly concerned about those
patients who required a valve repair using a patch, and that ideally will be class
3 patients or those who had perforation of a leaﬂet. So if you have a defect, you
need to repair that defect. Certainly in the bicuspid population, when we do
the reimplantation technique with more intense annuloplasty, that will result in
more additional tissue of the cusp being available. So after resection, a simple
direct closure may be done, so the use of patch could be limited in those par-
ticular patients. This is all I can say about this at this time.
Dr Thelin: But that means that in some subgroups you have moved away
from the use of patches and gone to more traditional methods in one way or
another?
Dr Mosala Nezhad: For indicated patients, yes. If the indication for the use
of patch is there and it is inevitable, yes, we do the repair surgery.
Dr M. Ahmed-Nasr (Cairo, Egypt): We have used fresh autologous pericar-
dium and we had a bad experience; it degenerates very rapidly. And then when
we started to tan this pericardium using glutaraldehyde, but in a diluted form,
and then washed it many times before use, we had better results; is this your ex-
perience?
Dr Mosala Nezhad: Was this experience in rheumatic or non-rheumatic
patients?
Dr Ahmed-Nasr: In rheumatic.
Dr Mosala Nezhad: In rheumatic!
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